Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Inserm, the French National Institute of Health and Medical Research (Institut national de la santé et de la recherche médicale), is a public scientific and technological institution operating under the joint authority of the French Ministry of Health and the Ministry of Research. It is the sole French public research organization entirely dedicated to human health. Its nearly 14,000 researchers, engineers, technicians, and administrative staff strive to improve health for all through advancing knowledge about life and disease, innovating in treatments, and conducting public health research. Inserm plays a crucial role in the French research ecosystem, fostering collaborations and translating scientific discoveries into tangible health benefits across a wide spectrum of medical fields.
The headquarters serves as the core for central administration, strategic planning, national research coordination, international relations, policy development, and communication for all Inserm research units across France and its international partnerships.
Located in the 13th arrondissement of Paris, a dynamic and modern district. The building is a functional administrative center designed to support complex national research operations rather than being an architectural landmark itself.
A highly professional, collaborative, and mission-driven environment, deeply focused on scientific excellence, ethical research, innovation, and public service. The culture promotes interdisciplinary work and knowledge sharing.
The Paris headquarters is pivotal for orchestrating and unifying the diverse research efforts of Inserm's numerous laboratories and units throughout France. It ensures alignment with national health priorities and facilitates the institute's role as a leading voice in medical research.
While primarily a French national institute, Inserm maintains a strong global presence through extensive international collaborations, including joint research units with foreign institutions (e.g., UMI with NIH in the USA, UMI with A*STAR in Singapore), active participation in European framework programs (like Horizon Europe) and international research consortia. Inserm researchers are engaged in projects worldwide, contributing to global scientific advancements and addressing transnational health challenges. The institute supports researcher mobility, hosts international scientists, and has representative offices or associated laboratories in various countries to foster these international ties.
101 Rue de Tolbiac
Paris
Île-de-France
France
Address: Inserm Délégation Régionale Hauts-de-France, Pôle Recherche, Rue du Professeur Laguesse, 59045 Lille Cedex
To implement Inserm's national strategy at a regional level, supporting diverse research themes pertinent to local health challenges and scientific strengths, and fostering partnerships with universities and hospitals.
Address: Inserm Délégation Régionale Provence-Alpes-Côte d'Azur et Corse, Parc Valente, Bâtiment A, 18 Traverse de la Montre, 13011 Marseille
To coordinate and promote high-level medical research within the region, connecting Inserm units with academic institutions, healthcare providers, and industry to advance health innovation and address regional health priorities.
Address: Inserm Délégation Régionale Grand Est, Parc d'Innovation, Rue Laurent Fries, B.P. 10373, 67411 Illkirch Cedex
To drive biomedical research and innovation in Eastern France, leveraging regional expertise and infrastructure, including strong ties with European partners due to its location, to contribute to national and international health advancements.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, INSERM' leadership includes:
INSERM has been backed by several prominent investors over the years, including:
The most significant executive change at Inserm in the last 12 months was the appointment of Professor Didier Samuel as interim Chairman and CEO in October 2023. This followed the conclusion of Gilles Bloch's term in the same role. Other internal directorial appointments or minor shifts may occur but typically are not announced as major executive events.
Discover the tools INSERM uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Inserm, like many large French research and academic institutions, typically utilizes a standardized email format for its personnel. The most common and predictable format is based on the employee's first and last name.
firstname.lastname@inserm.fr
Format
marie.curie@inserm.fr
Example
80%
Success rate
Inserm Press Room • June 13, 2024
Researchers from Inserm, CNRS, and Université Paris Cité have identified a rare genetic mutation in the SORL1 gene that appears to protect against the most common genetic form of early-onset Alzheimer's disease. This discovery, published in Molecular Psychiatry, opens new avenues for therapeutic research targeting the SORL1 protein....more
Inserm Press Room • May 28, 2024
A new Inserm study, conducted in collaboration with Santé publique France and the Caisse centrale de la Mutualité Sociale Agricole, reveals a significant association between occupational exposure to pesticides and an increased risk of developing Parkinson's disease. The findings underscore the need for stricter regulations and protective measures for agricultural workers....more
Inserm Press Room • April 25, 2024
Researchers at Inserm have developed a predictive tool using clinical and imaging data to identify patients with depression who are less likely to respond to conventional antidepressant treatments. This could help personalize therapeutic strategies and improve patient outcomes....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including INSERM, are just a search away.